Acute or destabilized heart failure (DHF) is characterized by new or worsening signs and symptoms of heart failure leading to admission to an emergency department. Biomarkers may support the diagnosis, the prognosis and the management of DHF patients. The aim of this review article is to discuss and evaluate the clinical usefulness of both recognized and potential new biomarker tests for use in heart failure
Heart failure (HF) represents fatal endpoint of all cardiovascular diseases. Acute and chronic HF is...
A contemporary review of the diagnosis of heart failure as part of a special heart failure issue. Th...
Aims: This retrospective analysis sought to identify markers that might distinguish between acute he...
Heart failure is a global health problem. An episode of acute heart failure (AHF) is a period of sub...
failure (HF) syndromes has been viewed as an elective supplement to diagnostic evaluation of patient...
Acute heart failure (AHF) affects millions of people worldwide, and it is a potentially life-threate...
Heart failure is a common presentation to the emergency department (ED), which can be confusedwith o...
High mortality, morbility and hospitalization as a result of acute heart failure (AHF) represents an...
This retrospective analysis sought to identify markers that might distinguish between acute heart fa...
New biomarkers are being evaluated for their ability to advance the management of patients with hear...
Heart failure (HF) is the end result of many different cardiac and non-cardiac abnormalities leading...
303-313Heart failure (HF) remains the leading cause of death in the elderly population. Since last d...
AimsThis retrospective analysis sought to identify markers that might distinguish between acute hear...
Managing patients with heart failure (HF) is a challenging task within itself, but the presence of a...
Heart failure (HF) is a complex clinical syndrome that results in the impairment of the heart’s abil...
Heart failure (HF) represents fatal endpoint of all cardiovascular diseases. Acute and chronic HF is...
A contemporary review of the diagnosis of heart failure as part of a special heart failure issue. Th...
Aims: This retrospective analysis sought to identify markers that might distinguish between acute he...
Heart failure is a global health problem. An episode of acute heart failure (AHF) is a period of sub...
failure (HF) syndromes has been viewed as an elective supplement to diagnostic evaluation of patient...
Acute heart failure (AHF) affects millions of people worldwide, and it is a potentially life-threate...
Heart failure is a common presentation to the emergency department (ED), which can be confusedwith o...
High mortality, morbility and hospitalization as a result of acute heart failure (AHF) represents an...
This retrospective analysis sought to identify markers that might distinguish between acute heart fa...
New biomarkers are being evaluated for their ability to advance the management of patients with hear...
Heart failure (HF) is the end result of many different cardiac and non-cardiac abnormalities leading...
303-313Heart failure (HF) remains the leading cause of death in the elderly population. Since last d...
AimsThis retrospective analysis sought to identify markers that might distinguish between acute hear...
Managing patients with heart failure (HF) is a challenging task within itself, but the presence of a...
Heart failure (HF) is a complex clinical syndrome that results in the impairment of the heart’s abil...
Heart failure (HF) represents fatal endpoint of all cardiovascular diseases. Acute and chronic HF is...
A contemporary review of the diagnosis of heart failure as part of a special heart failure issue. Th...
Aims: This retrospective analysis sought to identify markers that might distinguish between acute he...